European Case Law Identifier: | ECLI:EP:BA:2016:T059813.20160714 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 14 July 2016 | ||||||||
Case number: | T 0598/13 | ||||||||
Application number: | 05380116.3 | ||||||||
IPC class: | A61K 51/08 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | Therapeutic human albumin solutions with low prekallicrein activator (PKA) activity and process for obtaining them | ||||||||
Applicant name: | Grifols, S.A. | ||||||||
Opponent name: | CSL Behring GmbH | ||||||||
Board: | 3.3.07 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Evidence submitted in appeal proceedings Evidence - admitted (yes) Appeal decision - remittal to the department of first instance (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t130598eu1.html
Date retrieved: 17 May 2021